EGFR and neoplasm: Studies of luminal-A breast cancer cells, that by definition are responsive to estrogen, demonstrated that the hormone induced the expression of CXCL12 and of CXCR4 in the tumor cells, leading to enhanced tumor cell growth, and also gave rise to EGFR transactivation and then to increased DNA synthesis (52–54).